Mao, Y. et al. 2023. Development of monoclonal antibodies targeting Her-2 and EGFR in the treatment of breast cancer. Highlights in Science, Engineering and Technology. 74, (Dec. 2023), 550–555. DOI:https://doi.org/10.54097/hk6fb188.